Home
Genzyme

Genzyme Market Share Analysis for January 2026

Genzyme was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world.

Health > Biotechnology and Pharmaceuticals

Domaingenzyme.com

Year Founded1981

Employees201 - 500

Annual Revenue> $1B

Genzyme

Genzyme (including company regionals)

genzyme.com

See more website traffic and engagement information

Genzyme Revenue up to January 2026 is > 1B

revenue generated by Genzyme top domains

Genzyme top domains revenue over 3 years

Revenue for Genzyme top domains

genzyme.com> 1B

See more with Sales Intelligence

Total visits to Genzyme's top domains

Understand Genzyme market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Genzyme's top domains

Analyze Genzyme engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Genzyme's top domains

See how Genzyme keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Genzyme top competitors by domain

Top similar sites in January 2026, ranked by their affinity

amgen.comCompany NameAmgenEmployees> 10001HQUnited States, California, Thousand OaksAnnual revenue> $1BTotal visits692.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Genzyme

These are the website technologies, by industry, used by Genzyme top domains

Audio Video Media (3)

YouTube

Content Management System (2)

Kentico

Conversion & Analytics (2)

Google Analytics

Widget (2)

reCAPTCHA

More Technologies

7

See all

News & Signals from Genzyme

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLabCorp merged with Genzyme Corp on Jan 1st '10.LabCorp acquired or merged with Genzyme in 2010.

NewsGenzyme Corp launches Humanitarian Program.Recognizing that problem, Genzyme (now Sanofi) launched a Humanitarian Program to make its enzyme replacement therapies accessible to all patients as soon as the first such therapy, for Gaucher disease, received FDA approval in 1991.

NewsGenzyme Corp receives award LEED Platinum certificate for Building Design and Construction.Genzyme center was awarded the LEED Platinum certificate for Building Design and Construction.